Global Granulocyte Macrophage Colony Stimulating Factor Market Growth 2023-2028

Report ID: 1503402 | Published Date: Jan 2025 | No. of Page: 108 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Granulocyte Macrophage Colony Stimulating Factor Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for Granulocyte Macrophage Colony Stimulating Factor by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for Granulocyte Macrophage Colony Stimulating Factor by Country/Region, 2017, 2022 & 2028
    2.2 Granulocyte Macrophage Colony Stimulating Factor Segment by Type
        2.2.1 CG-0070
        2.2.2 Gimsilumab
        2.2.3 GSK-3196165
        2.2.4 Lenzilumab
        2.2.5 MGN-1601
        2.2.6 Others
    2.3 Granulocyte Macrophage Colony Stimulating Factor Sales by Type
        2.3.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2017-2022)
        2.3.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue and Market Share by Type (2017-2022)
        2.3.3 Global Granulocyte Macrophage Colony Stimulating Factor Sale Price by Type (2017-2022)
    2.4 Granulocyte Macrophage Colony Stimulating Factor Segment by Application
        2.4.1 Solid Tumor
        2.4.2 Lymphoma
        2.4.3 Kidney Cancer
        2.4.4 Lung Disease
        2.4.5 Others
    2.5 Granulocyte Macrophage Colony Stimulating Factor Sales by Application
        2.5.1 Global Granulocyte Macrophage Colony Stimulating Factor Sale Market Share by Application (2017-2022)
        2.5.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue and Market Share by Application (2017-2022)
        2.5.3 Global Granulocyte Macrophage Colony Stimulating Factor Sale Price by Application (2017-2022)
3 Global Granulocyte Macrophage Colony Stimulating Factor by Company
    3.1 Global Granulocyte Macrophage Colony Stimulating Factor Breakdown Data by Company
        3.1.1 Global Granulocyte Macrophage Colony Stimulating Factor Annual Sales by Company (2020-2022)
        3.1.2 Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Company (2020-2022)
    3.2 Global Granulocyte Macrophage Colony Stimulating Factor Annual Revenue by Company (2020-2022)
        3.2.1 Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Company (2020-2022)
        3.2.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Company (2020-2022)
    3.3 Global Granulocyte Macrophage Colony Stimulating Factor Sale Price by Company
    3.4 Key Manufacturers Granulocyte Macrophage Colony Stimulating Factor Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Granulocyte Macrophage Colony Stimulating Factor Product Location Distribution
        3.4.2 Players Granulocyte Macrophage Colony Stimulating Factor Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Granulocyte Macrophage Colony Stimulating Factor by Geographic Region
    4.1 World Historic Granulocyte Macrophage Colony Stimulating Factor Market Size by Geographic Region (2017-2022)
        4.1.1 Global Granulocyte Macrophage Colony Stimulating Factor Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global Granulocyte Macrophage Colony Stimulating Factor Annual Revenue by Geographic Region
    4.2 World Historic Granulocyte Macrophage Colony Stimulating Factor Market Size by Country/Region (2017-2022)
        4.2.1 Global Granulocyte Macrophage Colony Stimulating Factor Annual Sales by Country/Region (2017-2022)
        4.2.2 Global Granulocyte Macrophage Colony Stimulating Factor Annual Revenue by Country/Region
    4.3 Americas Granulocyte Macrophage Colony Stimulating Factor Sales Growth
    4.4 APAC Granulocyte Macrophage Colony Stimulating Factor Sales Growth
    4.5 Europe Granulocyte Macrophage Colony Stimulating Factor Sales Growth
    4.6 Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales Growth
5 Americas
    5.1 Americas Granulocyte Macrophage Colony Stimulating Factor Sales by Country
        5.1.1 Americas Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2017-2022)
        5.1.2 Americas Granulocyte Macrophage Colony Stimulating Factor Revenue by Country (2017-2022)
    5.2 Americas Granulocyte Macrophage Colony Stimulating Factor Sales by Type
    5.3 Americas Granulocyte Macrophage Colony Stimulating Factor Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Granulocyte Macrophage Colony Stimulating Factor Sales by Region
        6.1.1 APAC Granulocyte Macrophage Colony Stimulating Factor Sales by Region (2017-2022)
        6.1.2 APAC Granulocyte Macrophage Colony Stimulating Factor Revenue by Region (2017-2022)
    6.2 APAC Granulocyte Macrophage Colony Stimulating Factor Sales by Type
    6.3 APAC Granulocyte Macrophage Colony Stimulating Factor Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Granulocyte Macrophage Colony Stimulating Factor by Country
        7.1.1 Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2017-2022)
        7.1.2 Europe Granulocyte Macrophage Colony Stimulating Factor Revenue by Country (2017-2022)
    7.2 Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Type
    7.3 Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor by Country
        8.1.1 Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2017-2022)
        8.1.2 Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Revenue by Country (2017-2022)
    8.2 Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Type
    8.3 Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Granulocyte Macrophage Colony Stimulating Factor
    10.3 Manufacturing Process Analysis of Granulocyte Macrophage Colony Stimulating Factor
    10.4 Industry Chain Structure of Granulocyte Macrophage Colony Stimulating Factor
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Granulocyte Macrophage Colony Stimulating Factor Distributors
    11.3 Granulocyte Macrophage Colony Stimulating Factor Customer
12 World Forecast Review for Granulocyte Macrophage Colony Stimulating Factor by Geographic Region
    12.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Region
        12.1.1 Global Granulocyte Macrophage Colony Stimulating Factor Forecast by Region (2023-2028)
        12.1.2 Global Granulocyte Macrophage Colony Stimulating Factor Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Granulocyte Macrophage Colony Stimulating Factor Forecast by Type
    12.7 Global Granulocyte Macrophage Colony Stimulating Factor Forecast by Application
13 Key Players Analysis
    13.1 Aduro BioTech Inc
        13.1.1 Aduro BioTech Inc Company Information
        13.1.2 Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Product Offered
        13.1.3 Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Aduro BioTech Inc Main Business Overview
        13.1.5 Aduro BioTech Inc Latest Developments
    13.2 Amgen Inc
        13.2.1 Amgen Inc Company Information
        13.2.2 Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Product Offered
        13.2.3 Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 Amgen Inc Main Business Overview
        13.2.5 Amgen Inc Latest Developments
    13.3 BriaCell Therapeutics Corp
        13.3.1 BriaCell Therapeutics Corp Company Information
        13.3.2 BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Product Offered
        13.3.3 BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 BriaCell Therapeutics Corp Main Business Overview
        13.3.5 BriaCell Therapeutics Corp Latest Developments
    13.4 Cold Genesys Inc
        13.4.1 Cold Genesys Inc Company Information
        13.4.2 Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Product Offered
        13.4.3 Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 Cold Genesys Inc Main Business Overview
        13.4.5 Cold Genesys Inc Latest Developments
    13.5 GlaxoSmithKline Plc
        13.5.1 GlaxoSmithKline Plc Company Information
        13.5.2 GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Product Offered
        13.5.3 GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 GlaxoSmithKline Plc Main Business Overview
        13.5.5 GlaxoSmithKline Plc Latest Developments
    13.6 Humanigen Inc
        13.6.1 Humanigen Inc Company Information
        13.6.2 Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Product Offered
        13.6.3 Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 Humanigen Inc Main Business Overview
        13.6.5 Humanigen Inc Latest Developments
    13.7 Mologen AG
        13.7.1 Mologen AG Company Information
        13.7.2 Mologen AG Granulocyte Macrophage Colony Stimulating Factor Product Offered
        13.7.3 Mologen AG Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 Mologen AG Main Business Overview
        13.7.5 Mologen AG Latest Developments
    13.8 Morphotek Inc
        13.8.1 Morphotek Inc Company Information
        13.8.2 Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Product Offered
        13.8.3 Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 Morphotek Inc Main Business Overview
        13.8.5 Morphotek Inc Latest Developments
    13.9 Sillajen Biotherapeutics
        13.9.1 Sillajen Biotherapeutics Company Information
        13.9.2 Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Product Offered
        13.9.3 Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 Sillajen Biotherapeutics Main Business Overview
        13.9.5 Sillajen Biotherapeutics Latest Developments
    13.10 Takeda Pharmaceutical Co Ltd
        13.10.1 Takeda Pharmaceutical Co Ltd Company Information
        13.10.2 Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Product Offered
        13.10.3 Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)
        13.10.4 Takeda Pharmaceutical Co Ltd Main Business Overview
        13.10.5 Takeda Pharmaceutical Co Ltd Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. Granulocyte Macrophage Colony Stimulating Factor Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Granulocyte Macrophage Colony Stimulating Factor Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of CG-0070
    Table 4. Major Players of Gimsilumab
    Table 5. Major Players of GSK-3196165
    Table 6. Major Players of Lenzilumab
    Table 7. Major Players of MGN-1601
    Table 8. Major Players of Others
    Table 9. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2017-2022) & (K Pcs)
    Table 10. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2017-2022)
    Table 11. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Type (2017-2022) & ($ million)
    Table 12. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Type (2017-2022)
    Table 13. Global Granulocyte Macrophage Colony Stimulating Factor Sale Price by Type (2017-2022) & (USD/Pcs)
    Table 14. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2017-2022) & (K Pcs)
    Table 15. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2017-2022)
    Table 16. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Application (2017-2022)
    Table 17. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Application (2017-2022)
    Table 18. Global Granulocyte Macrophage Colony Stimulating Factor Sale Price by Application (2017-2022) & (USD/Pcs)
    Table 19. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Company (2020-2022) & (K Pcs)
    Table 20. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Company (2020-2022)
    Table 21. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Company (2020-2022) ($ Millions)
    Table 22. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Company (2020-2022)
    Table 23. Global Granulocyte Macrophage Colony Stimulating Factor Sale Price by Company (2020-2022) & (USD/Pcs)
    Table 24. Key Manufacturers Granulocyte Macrophage Colony Stimulating Factor Producing Area Distribution and Sales Area
    Table 25. Players Granulocyte Macrophage Colony Stimulating Factor Products Offered
    Table 26. Granulocyte Macrophage Colony Stimulating Factor Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 27. New Products and Potential Entrants
    Table 28. Mergers & Acquisitions, Expansion
    Table 29. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Geographic Region (2017-2022) & (K Pcs)
    Table 30. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share Geographic Region (2017-2022)
    Table 31. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 32. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Geographic Region (2017-2022)
    Table 33. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Country/Region (2017-2022) & (K Pcs)
    Table 34. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country/Region (2017-2022)
    Table 35. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Country/Region (2017-2022) & ($ millions)
    Table 36. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Country/Region (2017-2022)
    Table 37. Americas Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2017-2022) & (K Pcs)
    Table 38. Americas Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country (2017-2022)
    Table 39. Americas Granulocyte Macrophage Colony Stimulating Factor Revenue by Country (2017-2022) & ($ Millions)
    Table 40. Americas Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Country (2017-2022)
    Table 41. Americas Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2017-2022) & (K Pcs)
    Table 42. Americas Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2017-2022)
    Table 43. Americas Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2017-2022) & (K Pcs)
    Table 44. Americas Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2017-2022)
    Table 45. APAC Granulocyte Macrophage Colony Stimulating Factor Sales by Region (2017-2022) & (K Pcs)
    Table 46. APAC Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Region (2017-2022)
    Table 47. APAC Granulocyte Macrophage Colony Stimulating Factor Revenue by Region (2017-2022) & ($ Millions)
    Table 48. APAC Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Region (2017-2022)
    Table 49. APAC Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2017-2022) & (K Pcs)
    Table 50. APAC Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2017-2022)
    Table 51. APAC Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2017-2022) & (K Pcs)
    Table 52. APAC Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2017-2022)
    Table 53. Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2017-2022) & (K Pcs)
    Table 54. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country (2017-2022)
    Table 55. Europe Granulocyte Macrophage Colony Stimulating Factor Revenue by Country (2017-2022) & ($ Millions)
    Table 56. Europe Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Country (2017-2022)
    Table 57. Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2017-2022) & (K Pcs)
    Table 58. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2017-2022)
    Table 59. Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2017-2022) & (K Pcs)
    Table 60. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2017-2022)
    Table 61. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2017-2022) & (K Pcs)
    Table 62. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country (2017-2022)
    Table 63. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Revenue by Country (2017-2022) & ($ Millions)
    Table 64. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Country (2017-2022)
    Table 65. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2017-2022) & (K Pcs)
    Table 66. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2017-2022)
    Table 67. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2017-2022) & (K Pcs)
    Table 68. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2017-2022)
    Table 69. Key Market Drivers & Growth Opportunities of Granulocyte Macrophage Colony Stimulating Factor
    Table 70. Key Market Challenges & Risks of Granulocyte Macrophage Colony Stimulating Factor
    Table 71. Key Industry Trends of Granulocyte Macrophage Colony Stimulating Factor
    Table 72. Granulocyte Macrophage Colony Stimulating Factor Raw Material
    Table 73. Key Suppliers of Raw Materials
    Table 74. Granulocyte Macrophage Colony Stimulating Factor Distributors List
    Table 75. Granulocyte Macrophage Colony Stimulating Factor Customer List
    Table 76. Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Region (2023-2028) & (K Pcs)
    Table 77. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Forecast by Region
    Table 78. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 79. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share Forecast by Region (2023-2028)
    Table 80. Americas Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Country (2023-2028) & (K Pcs)
    Table 81. Americas Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 82. APAC Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Region (2023-2028) & (K Pcs)
    Table 83. APAC Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 84. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Country (2023-2028) & (K Pcs)
    Table 85. Europe Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 86. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Country (2023-2028) & (K Pcs)
    Table 87. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 88. Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Type (2023-2028) & (K Pcs)
    Table 89. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share Forecast by Type (2023-2028)
    Table 90. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 91. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share Forecast by Type (2023-2028)
    Table 92. Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Application (2023-2028) & (K Pcs)
    Table 93. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share Forecast by Application (2023-2028)
    Table 94. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 95. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share Forecast by Application (2023-2028)
    Table 96. Aduro BioTech Inc Basic Information, Granulocyte Macrophage Colony Stimulating Factor Manufacturing Base, Sales Area and Its Competitors
    Table 97. Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Product Offered
    Table 98. Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 99. Aduro BioTech Inc Main Business
    Table 100. Aduro BioTech Inc Latest Developments
    Table 101. Amgen Inc Basic Information, Granulocyte Macrophage Colony Stimulating Factor Manufacturing Base, Sales Area and Its Competitors
    Table 102. Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Product Offered
    Table 103. Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 104. Amgen Inc Main Business
    Table 105. Amgen Inc Latest Developments
    Table 106. BriaCell Therapeutics Corp Basic Information, Granulocyte Macrophage Colony Stimulating Factor Manufacturing Base, Sales Area and Its Competitors
    Table 107. BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Product Offered
    Table 108. BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 109. BriaCell Therapeutics Corp Main Business
    Table 110. BriaCell Therapeutics Corp Latest Developments
    Table 111. Cold Genesys Inc Basic Information, Granulocyte Macrophage Colony Stimulating Factor Manufacturing Base, Sales Area and Its Competitors
    Table 112. Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Product Offered
    Table 113. Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 114. Cold Genesys Inc Main Business
    Table 115. Cold Genesys Inc Latest Developments
    Table 116. GlaxoSmithKline Plc Basic Information, Granulocyte Macrophage Colony Stimulating Factor Manufacturing Base, Sales Area and Its Competitors
    Table 117. GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Product Offered
    Table 118. GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 119. GlaxoSmithKline Plc Main Business
    Table 120. GlaxoSmithKline Plc Latest Developments
    Table 121. Humanigen Inc Basic Information, Granulocyte Macrophage Colony Stimulating Factor Manufacturing Base, Sales Area and Its Competitors
    Table 122. Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Product Offered
    Table 123. Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 124. Humanigen Inc Main Business
    Table 125. Humanigen Inc Latest Developments
    Table 126. Mologen AG Basic Information, Granulocyte Macrophage Colony Stimulating Factor Manufacturing Base, Sales Area and Its Competitors
    Table 127. Mologen AG Granulocyte Macrophage Colony Stimulating Factor Product Offered
    Table 128. Mologen AG Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 129. Mologen AG Main Business
    Table 130. Mologen AG Latest Developments
    Table 131. Morphotek Inc Basic Information, Granulocyte Macrophage Colony Stimulating Factor Manufacturing Base, Sales Area and Its Competitors
    Table 132. Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Product Offered
    Table 133. Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 134. Morphotek Inc Main Business
    Table 135. Morphotek Inc Latest Developments
    Table 136. Sillajen Biotherapeutics Basic Information, Granulocyte Macrophage Colony Stimulating Factor Manufacturing Base, Sales Area and Its Competitors
    Table 137. Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Product Offered
    Table 138. Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 139. Sillajen Biotherapeutics Main Business
    Table 140. Sillajen Biotherapeutics Latest Developments
    Table 141. Takeda Pharmaceutical Co Ltd Basic Information, Granulocyte Macrophage Colony Stimulating Factor Manufacturing Base, Sales Area and Its Competitors
    Table 142. Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Product Offered
    Table 143. Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 144. Takeda Pharmaceutical Co Ltd Main Business
    Table 145. Takeda Pharmaceutical Co Ltd Latest Developments
List of Figures
    Figure 1. Picture of Granulocyte Macrophage Colony Stimulating Factor
    Figure 2. Granulocyte Macrophage Colony Stimulating Factor Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate 2017-2028 (K Pcs)
    Figure 7. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Granulocyte Macrophage Colony Stimulating Factor Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of CG-0070
    Figure 10. Product Picture of Gimsilumab
    Figure 11. Product Picture of GSK-3196165
    Figure 12. Product Picture of Lenzilumab
    Figure 13. Product Picture of MGN-1601
    Figure 14. Product Picture of Others
    Figure 15. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type in 2021
    Figure 16. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Type (2017-2022)
    Figure 17. Granulocyte Macrophage Colony Stimulating Factor Consumed in Solid Tumor
    Figure 18. Global Granulocyte Macrophage Colony Stimulating Factor Market: Solid Tumor (2017-2022) & (K Pcs)
    Figure 19. Granulocyte Macrophage Colony Stimulating Factor Consumed in Lymphoma
    Figure 20. Global Granulocyte Macrophage Colony Stimulating Factor Market: Lymphoma (2017-2022) & (K Pcs)
    Figure 21. Granulocyte Macrophage Colony Stimulating Factor Consumed in Kidney Cancer
    Figure 22. Global Granulocyte Macrophage Colony Stimulating Factor Market: Kidney Cancer (2017-2022) & (K Pcs)
    Figure 23. Granulocyte Macrophage Colony Stimulating Factor Consumed in Lung Disease
    Figure 24. Global Granulocyte Macrophage Colony Stimulating Factor Market: Lung Disease (2017-2022) & (K Pcs)
    Figure 25. Granulocyte Macrophage Colony Stimulating Factor Consumed in Others
    Figure 26. Global Granulocyte Macrophage Colony Stimulating Factor Market: Others (2017-2022) & (K Pcs)
    Figure 27. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2017-2022)
    Figure 28. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Application in 2021
    Figure 29. Granulocyte Macrophage Colony Stimulating Factor Revenue Market by Company in 2021 ($ Million)
    Figure 30. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Company in 2021
    Figure 31. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Geographic Region (2017-2022)
    Figure 32. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Geographic Region in 2021
    Figure 33. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Region (2017-2022)
    Figure 34. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Country/Region in 2021
    Figure 35. Americas Granulocyte Macrophage Colony Stimulating Factor Sales 2017-2022 (K Pcs)
    Figure 36. Americas Granulocyte Macrophage Colony Stimulating Factor Revenue 2017-2022 ($ Millions)
    Figure 37. APAC Granulocyte Macrophage Colony Stimulating Factor Sales 2017-2022 (K Pcs)
    Figure 38. APAC Granulocyte Macrophage Colony Stimulating Factor Revenue 2017-2022 ($ Millions)
    Figure 39. Europe Granulocyte Macrophage Colony Stimulating Factor Sales 2017-2022 (K Pcs)
    Figure 40. Europe Granulocyte Macrophage Colony Stimulating Factor Revenue 2017-2022 ($ Millions)
    Figure 41. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales 2017-2022 (K Pcs)
    Figure 42. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Revenue 2017-2022 ($ Millions)
    Figure 43. Americas Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country in 2021
    Figure 44. Americas Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Country in 2021
    Figure 45. United States Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2017-2022 ($ Millions)
    Figure 46. Canada Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2017-2022 ($ Millions)
    Figure 47. Mexico Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2017-2022 ($ Millions)
    Figure 48. Brazil Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2017-2022 ($ Millions)
    Figure 49. APAC Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Region in 2021
    Figure 50. APAC Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Regions in 2021
    Figure 51. China Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2017-2022 ($ Millions)
    Figure 52. Japan Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2017-2022 ($ Millions)
    Figure 53. South Korea Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2017-2022 ($ Millions)
    Figure 54. Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2017-2022 ($ Millions)
    Figure 55. India Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2017-2022 ($ Millions)
    Figure 56. Australia Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2017-2022 ($ Millions)
    Figure 57. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country in 2021
    Figure 58. Europe Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Country in 2021
    Figure 59. Germany Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2017-2022 ($ Millions)
    Figure 60. France Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2017-2022 ($ Millions)
    Figure 61. UK Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2017-2022 ($ Millions)
    Figure 62. Italy Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2017-2022 ($ Millions)
    Figure 63. Russia Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2017-2022 ($ Millions)
    Figure 64. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country in 2021
    Figure 65. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Country in 2021
    Figure 66. Egypt Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2017-2022 ($ Millions)
    Figure 67. South Africa Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2017-2022 ($ Millions)
    Figure 68. Israel Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2017-2022 ($ Millions)
    Figure 69. Turkey Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2017-2022 ($ Millions)
    Figure 70. GCC Country Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2017-2022 ($ Millions)
    Figure 71. Manufacturing Cost Structure Analysis of Granulocyte Macrophage Colony Stimulating Factor in 2021
    Figure 72. Manufacturing Process Analysis of Granulocyte Macrophage Colony Stimulating Factor
    Figure 73. Industry Chain Structure of Granulocyte Macrophage Colony Stimulating Factor
    Figure 74. Channels of Distribution
    Figure 75. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Granulocyte Macrophage Colony Stimulating Factor Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Granulocyte Macrophage Colony Stimulating Factor Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Granulocyte Macrophage Colony Stimulating Factor Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports